BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 17520825)

  • 1. [Detection of binding activity and biologic effect of a novel alpha-melanocyte-stimulating hormone analogue].
    Ying Y; Lan XP; Tian YP
    Yao Xue Xue Bao; 2007 Mar; 42(3):269-73. PubMed ID: 17520825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-operative regulation of ligand binding to melanocortin receptor subtypes: evidence for interacting binding sites.
    Kopanchuk S; Veiksina S; Petrovska R; Mutule I; Szardenings M; Rinken A; Wikberg JE
    Eur J Pharmacol; 2005 Apr; 512(2-3):85-95. PubMed ID: 15840392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of novel melanocortin4 receptor selective MSH analogues.
    Schiöth HB; Mutulis F; Muceniece R; Prusis P; Wikberg JE
    Br J Pharmacol; 1998 May; 124(1):75-82. PubMed ID: 9630346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cysteine residues are involved in structure and function of melanocortin 1 receptor: Substitution of a cysteine residue in transmembrane segment two converts an agonist to antagonist.
    Frändberg PA; Doufexis M; Kapas S; Chhajlani V
    Biochem Biophys Res Commun; 2001 Mar; 281(4):851-7. PubMed ID: 11237737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic lactam alpha-melanotropin analogues of Ac-Nle4-cyclo[Asp5, D-Phe7,Lys10] alpha-melanocyte-stimulating hormone-(4-10)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors.
    Hruby VJ; Lu D; Sharma SD; Castrucci AL; Kesterson RA; al-Obeidi FA; Hadley ME; Cone RD
    J Med Chem; 1995 Sep; 38(18):3454-61. PubMed ID: 7658432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of prototype peptidomimetic agonists at the human melanocortin receptors MC1R and MC4R.
    Haskell-Luevano C; Hendrata S; North C; Sawyer TK; Hadley ME; Hruby VJ; Dickinson C; Gantz I
    J Med Chem; 1997 Jul; 40(14):2133-9. PubMed ID: 9216831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further pharmacological characterization of the selective melanocortin 4 receptor antagonist HS014: comparison with SHU9119.
    Schiöth HB; Muceniece R; Mutulis F; Bouifrouri AA; Mutule I; Wikberg JE
    Neuropeptides; 1999 Jun; 33(3):191-6. PubMed ID: 10657491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Betulin binds to melanocortin receptors and antagonizes alpha-melanocyte stimulating hormone induced cAMP generation in mouse melanoma cells.
    Muceniece R; Saleniece K; Riekstina U; Krigere L; Tirzitis G; Ancans J
    Cell Biochem Funct; 2007; 25(5):591-6. PubMed ID: 17605140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenylguanidines as selective nonpeptide melanocortin-5 receptor antagonists.
    Chen C; Yu J; Fleck BA; Hoare SR; Saunders J; Foster AC
    J Med Chem; 2004 Jul; 47(16):4083-8. PubMed ID: 15267247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerating sensory recovery after sciatic nerve crush: non-selective versus melanocortin MC4 receptor-selective peptides.
    Nijenhuis WA; Wanders N; Kruijtzer JA; Liskamp RM; Gispen WH; Adan RA
    Eur J Pharmacol; 2004 Jul; 495(2-3):145-52. PubMed ID: 15249163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationships of gamma-MSH analogues at the human melanocortin MC3, MC4, and MC5 receptors. Discovery of highly selective hMC3R, hMC4R, and hMC5R analogues.
    Balse-Srinivasan P; Grieco P; Cai M; Trivedi D; Hruby VJ
    J Med Chem; 2003 Nov; 46(23):4965-73. PubMed ID: 14584947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of melanocortin peptides on neural melanocortin receptors.
    Adan RA; Cone RD; Burbach JP; Gispen WH
    Mol Pharmacol; 1994 Dec; 46(6):1182-90. PubMed ID: 7808440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of melanocortin receptor subtypes by radioligand binding analysis.
    Schiöth HB; Muceniece R; Wikberg JE; Chhajlani V
    Eur J Pharmacol; 1995 Feb; 288(3):311-7. PubMed ID: 7774675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the binding of MSH-B, HB-228, GHRP-6 and 153N-6 to the human melanocortin receptor subtypes.
    Schiöth HB; Muceniece R; Wikberg JE
    Neuropeptides; 1997 Dec; 31(6):565-71. PubMed ID: 9574823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of intracellular free calcium in GH3 cells by gamma3-melanocyte-stimulating hormone. Involvement of a novel melanocortin receptor?
    Langouche L; Roudbaraki M; Pals K; Denef C
    Endocrinology; 2001 Jan; 142(1):257-66. PubMed ID: 11145589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long term orexigenic effect of a novel melanocortin 4 receptor selective antagonist.
    Skuladottir GV; Jonsson L; Skarphedinsson JO; Mutulis F; Muceniece R; Raine A; Mutule I; Helgason J; Prusis P; Wikberg JE; Schiöth HB
    Br J Pharmacol; 1999 Jan; 126(1):27-34. PubMed ID: 10051117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. γ₂-Melanocyte stimulation hormone (γ₂-MSH) truncation studies results in the cautionary note that γ₂-MSH is not selective for the mouse MC3R over the mouse MC5R.
    Joseph CG; Yao H; Scott JW; Sorensen NB; Marnane RN; Mountjoy KG; Haskell-Luevano C
    Peptides; 2010 Dec; 31(12):2304-13. PubMed ID: 20833220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agouti antagonism of melanocortin-4 receptor: greater effect with desacetyl-alpha-melanocyte-stimulating hormone (MSH) than with alpha-MSH.
    Mountjoy KG; Willard DH; Wilkison WO
    Endocrinology; 1999 May; 140(5):2167-72. PubMed ID: 10218968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationships of novel cyclic alpha-MSH/beta-MSH hybrid analogues that lead to potent and selective ligands for the human MC3R and human MC5R.
    Balse-Srinivasan P; Grieco P; Cai M; Trivedi D; Hruby VJ
    J Med Chem; 2003 Aug; 46(17):3728-33. PubMed ID: 12904077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the melanocyte stimulating hormones on food intake. Lack Of evidence to support a role for the melanocortin-3-receptor.
    Abbott CR; Rossi M; Kim M; AlAhmed SH; Taylor GM; Ghatei MA; Smith DM; Bloom SR
    Brain Res; 2000 Jun; 869(1-2):203-10. PubMed ID: 10865075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.